Merck Global Health Innovation Fund, Llc - Net Worth and Insider Trading
Merck Global Health Innovation Fund, Llc Net Worth
The estimated net worth of Merck Global Health Innovation Fund, Llc is at least $1 Million dollars as of 2024-09-23. Merck Global Health Innovation Fund, Llc is the 10% Owner of electroCore Inc and owns about 223,069 shares of electroCore Inc (ECOR) stock worth over $1 Million. Details can be seen in Merck Global Health Innovation Fund, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Merck Global Health Innovation Fund, Llc has not made any transactions after 2018-06-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Merck Global Health Innovation Fund, Llc
Merck Global Health Innovation Fund, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Merck Global Health Innovation Fund, Llc owns 2 companies in total, including electroCore Inc (ECOR) , and OpGen Inc (OPGN) .
Insider Ownership Summary of Merck Global Health Innovation Fund, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ECOR | electroCore Inc | 2018-06-21 | 10 percent owner |
| OPGN | OpGen Inc | 2015-07-14 | 10 percent owner |
Merck Global Health Innovation Fund, Llc Latest Holdings Summary
Merck Global Health Innovation Fund, Llc currently owns a total of 1 stock. Merck Global Health Innovation Fund, Llc owns 223,069 shares of electroCore Inc (ECOR) as of June 21, 2018, with a value of $1 Million.
Latest Holdings of Merck Global Health Innovation Fund, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ECOR | electroCore Inc | 2018-06-21 | 223,069 | 6.46 | 1,441,026 |
Holding Weightings of Merck Global Health Innovation Fund, Llc
Merck Global Health Innovation Fund, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Merck Global Health Innovation Fund, Llc has made a total of 0 transactions in electroCore Inc (ECOR) over the past 5 years. The most-recent trade in electroCore Inc is the acquisition of 11,111 shares on June 21, 2018, which cost Merck Global Health Innovation Fund, Llc around $2 Million.
Insider Trading History of Merck Global Health Innovation Fund, Llc
- 1
Merck Global Health Innovation Fund, Llc Trading Performance
GuruFocus tracks the stock performance after each of Merck Global Health Innovation Fund, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Merck Global Health Innovation Fund, Llc is -30.48%. GuruFocus also compares Merck Global Health Innovation Fund, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Merck Global Health Innovation Fund, Llc within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Merck Global Health Innovation Fund, Llc's insider trading performs compared to the benchmark.
Performance of Merck Global Health Innovation Fund, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -25.44 | | | | | |
| Relative Return to S&P 500(%) | -27.61 | | | | | |
Merck Global Health Innovation Fund, Llc Ownership Network
Merck Global Health Innovation Fund, Llc Owned Company Details
What does electroCore Inc do?
Who are the key executives at electroCore Inc?
Merck Global Health Innovation Fund, Llc is the 10 percent owner of electroCore Inc. Other key executives at electroCore Inc include director & 10 percent owner Thomas J. Errico , director & Chief Executive Officer Daniel S Goldberger , and director & 10 percent owner & See Remarks Joseph P Errico .
electroCore Inc (ECOR) Insider Trades Summary
Over the past 18 months, Merck Global Health Innovation Fund, Llc made no insider transaction in electroCore Inc (ECOR). Other recent insider transactions involving electroCore Inc (ECOR) include a net purchase of 140,996 shares made by Daniel S Goldberger , a net purchase of 5,000 shares made by Thomas J. Errico , and a net purchase of 1,000 shares made by John P Gandolfo .
In summary, during the past 3 months, insiders sold 0 shares of electroCore Inc (ECOR) in total and bought 5,000 shares, with a net purchase of 5,000 shares. During the past 18 months, 0 shares of electroCore Inc (ECOR) were sold and 146,996 shares were bought by its insiders, resulting in a net purchase of 146,996 shares.
electroCore Inc (ECOR)'s detailed insider trading history can be found in Insider Trading Tracker table.
electroCore Inc Insider Transactions
Merck Global Health Innovation Fund, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Merck Global Health Innovation Fund, Llc. You might contact Merck Global Health Innovation Fund, Llc via mailing address: One Merck Drive, Whitehouse Station Nj 08889.
Discussions on Merck Global Health Innovation Fund, Llc
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
